How it works
Get started by filling out the online enrollment application to find out if you are eligible for assistance.
NiceRx verifies your eligibility for medication assistance and notifies you if you are pre-qualified. The pharmaceutical company provides your medication for free, and you only pay our service fee.
We will request documents to be submitted by you and your healthcare provider that are required by the pharmaceutical company to complete your enrollment.
Once approved, the pharmaceutical company typically ships a 90-day supply of medication to your home or healthcare provider’s address. Final acceptance is determined by the pharmaceutical company.
Your monthly NovoSeven RT cost savings if eligible
If you are eligible to receive your NovoSeven RT prescription through the patient assistance program, your medication will be free. We charge a flat monthly service fee of $49 per medication to cover the cost of our services.
Am I eligible for NovoSeven RT patient assistance?
To be eligible for the NovoSeven RT patient assistance program, you will need to meet specific eligibility criteria set by the pharmaceutical company. At NiceRx, we review each NovoSeven RT enrollment application individually. The main factors considered are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for the NovoSeven RT patient assistance program?
Applying for the NovoSeven RT patient assistance program through NiceRx is simple. Begin by completing the enrollment application on our website. We will ask for details about your healthcare provider, your insurance plan, and your household income. This information is required by the pharmaceutical manufacturers that supply your medication. We may be able to help you access patient assistance for other medications as well as NovoSeven RT, so please tell us about any medications that you have been prescribed.
If we determine that you may be eligible for NovoSeven RT assistance, we will handle the full enrollment process on your behalf. We will work with your healthcare provider to prepare and submit all the documents required for you to enroll. If you are successfully enrolled in the NovoSeven RT patient assistance program, we will also request your NovoSeven RT medication refills on your behalf for up to 1 year. At the end of your enrollment period, we will contact you for updated details and seek to re-enroll you in the program.
Is NiceRx a NovoSeven RT coupons provider?
NiceRx does not provide NovoSeven RT coupons, discount cards or copay cards. We do not offer printable NovoSeven RT manufacturer coupons, NovoSeven RT discounts, rebates, NovoSeven RT savings cards, trial offers, or free samples. We are a service provider that helps eligible individuals access patient assistance programs. Our service cost is $49 a month per medication, so you will likely save more on your NovoSeven RT medication with NiceRx.
Can NiceRx help me get NovoSeven RT if I have insurance?
NiceRx may be able to help you access NovoSeven RT patient assistance if:
- You have a high copay or coinsurance responsibility for NovoSeven RT
- Your insurance company will not pay for your NovoSeven RT prescription
- You do not have insurance
Complete your enrollment application online to find out more.
How much does NovoSeven RT cost without insurance?
NovoSeven RT prices without insurance will vary by retailer. As a guide, NovoSeven RT intravenous powder for injection (1000 mcg (1 mg)) will typically cost around $2,600 for 1000 powders for injection.
How much does NovoSeven RT cost with insurance?
Your individual healthcare plan will determine the copay of NovoSeven RT with insurance. To find out what you will need to pay, contact your pharmacist or insurance provider. They will be able to calculate your copay with your current insurance.
What is NovoSeven RT?
NovoSeven RT is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Novo Nordisk, Inc. NovoSeven RT (Coagulation Factor VIIa [Recombinant]) is a clotting factor indicated for:
- Treatment of bleeding episodes and peri-operative management in adults and children with haemophilia A or hemophilia B with inhibitors to factor VIII or factor IX, congenital Factor VII deficiency, and Glanzmann’s thrombasthenia (a bleeding disorder that is caused by a blood abnormality) with refractoriness to platelet transfusions, with or without antibodies to platelets
- Treatment of bleeding episodes and peri-operative management in adults with acquired hemophilia
Serious arterial and venous thrombotic events following administration of NovoSeven RT have been reported. Discuss the increased risks and explain the signs and symptoms of thrombotic and thromboembolic events to patients who will receive treatment and monitor patients for signs or symptoms of activation of the coagulation system and for thrombosis.
What doses of NovoSeven RT are available?
NovoSeven RT is available as a lyophilized powder in single-use vials of 1, 2, 5, or 8 mg recombinant coagulation factor VIIa (FVIIa). After reconstitution, the final solution contains 1 mg per mL (1000 micrograms per mL) of recombinant FVIIa and may be stored either at room temperature or refrigerated for up to 3 hours. Do not freeze reconstituted NovoSeven (coagulation factor VIIa (recombinant)) or store it in syringes. NovoSeven RT is for intravenous bolus use only.
See the full prescribing information for the complete boxed warning and always speak with a healthcare professional about any changes to your dose so they can monitor and evaluate your condition.
NovoSeven RT active ingredients
Novoseven RT contains coagulation Factor VIIa, recombinant (rFVIIa) as the active ingredient.
NovoSeven RT side effects
The most common side effects of NovoSeven RT in clinical trials include:
- Thrombotic events
In rare instances, NovoSeven RT can cause more serious adverse effects. These can include:
- Serious arterial and venous thrombotic events may occur
- Anaphylaxis and other hypersensitivity reactions
Your doctor will assess the benefits of using NovoSeven RT against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of NovoSeven RT to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
NovoSeven RT drug interactions
NovoSeven RT can interact with other medications. These include:
- Activated or nonactivated prothrombin complex concentrates
- Other infusion solutions
- Coagulation factor XIII (FXIII)
This list is not exhaustive and other prescription drugs may interact with NovoSeven RT.
NovoSeven RT contraindications
You should not use NovoSeven RT if you:
- Are allergic to the active ingredient coagulation Factor VIIa, recombinant
- Are allergic to any of the other ingredients in NovoSeven RT
Talk to your doctor before using NovoSeven RT if you:
- Are taking any of the medications that could interact with NovoSeven RT
- Have known hypersensitivity to mouse, hamster, or bovine proteins
- Have coronary artery disease
- Have a severe injury or infection
- Have liver disease
- Are pregnant or are planning to become pregnant
- Are breastfeeding or are planning to breastfeed
NovoSeven RT generic
NovoSeven RT is the trademark brand name for coagulation Factor VIIa, recombinant manufactured by Novo Nordisk, Inc. A generic version of coagulation Factor VIIa, recombinant is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find NovoSeven RT savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.